FutureMS uses clinical examinations, brain imaging and genetics to try to predict how severe an individual's MS will be.


  • Multiple sclerosis

About the project

FutureMS is a Scotland-wide study for people who have recently been diagnosed with relapsing-remitting multiple sclerosis (RRMS).

When people are newly diagnosed with MS, they do not know what the future will hold. Most people experience occasional bouts of symptoms called 'relapses', but doctors cannot predict how often, or how severe these relapses will be. This can make it difficult for people to make decisions about their lifestyle, work and family. FutureMS aims to give people MS greater clarity about what their future may hold.

By supporting a more accurate prognosis for individuals, FutureMS will also help doctors to prescribe the right medication at the right time for the right person. This is sometimes called 'personalised medicine'.

For more information see the FutureMS website at future-ms.org.


Stratified Medicine Scotland Innovation Centre


Recruiting now


FutureMS Research Nurse
0131 465 9517

Eligibility criteria

People newly diagnosed with relapsing remitting MS may be eligible if they:

  • Are 18 years or over
  • Have not yet started on disease modifying treatment
  • Are happy to have blood tests and MRI brain imaging
  • Are not taking part in any other clinical trial
  • Are able to travel to Edinburgh, Dundee, Glasgow, Aberdeen or Inverness